In 2025, patient engagement is a measurable part of trial success
Opiate withdrawal may require DSIP exposure for a longer tenure, as this addiction is considered more resistant to alteration
Animal studies show actual tissue repair, not just symptom masking
The effect of cortistatin on a wide panel of inflammatory mediators could suppose a clear advantage versus several therapies designed to neutralize single inflammatory cytokines/chemokines or to inhibit intracellular factors involved in inflammatory signaling (i.e., NFkB) that have proven their efficacy in models of neuropathic pain [48,65,66]
Transformative Clinical Results for End-Users 85% Reduction in Hair Breakage: Achieved in a 12-week clinical trial, demonstrating superior hair strength
Pinealon protects the rat offspring from prenatal hyperhomocysteinemia